Xofluza (baloxavir marboxil) met its primary endpoint in the CENTERSTONE trial, reducing the odds of untreated household ...

Flu activity continues to ebb nationwide, with rates of influenza-like illness (ILI) dropping further last week, but ...

Fears the world is heading towards another pandemic are growing, as new data shows the spread of the deadly bird flu virus ...

The World Health Organization (WHO) said global vaccination rates were declining, raising concerns about rising preventable ...

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...

Vaccines have saved more than 154 million lives worldwide over the past 50 years. World Immunization Week is a timely ...

A landmark study reveals that a single oral dose of baloxavir marboxil (baloxavir) significantly reduces the transmission of influenza within households, marking a major advancement in influenza ...

Immunization efforts are under growing threat as misinformation, population growth, humanitarian crises and funding cuts jeopardize progress and leave millions of children, adolescents and adults at ...

One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about ...

A global pandemic agreement is a key pillar of the EU’s Global Health Strategy. On May 20, 2021, the European Council adopted ...

Outbreaks of vaccine-preventable diseases such as measles, meningitis, and yellow fever are on the rise globally amid ...